cp wire

CP Wire Articles

Gilead Sciences and Tango Therapeutics Form Partnership Worth Up to $1.7 Billion to Develop Next-Gen Immuno-Oncology Therapies
  • Tango will receive $50 million up front
  • The company could receive up to $1.7 billion in additional payments
  • The partnership will focus on building a pipeline of novel immuno... read more
Wed, 10/31/18 - 09:34 am
CymaBay Initiates Ph III Study of Primary Biliary Cholangitis Drug
  • 1 in 1000 women over the age of 40 lives with PBC
  • The company also has clinical trials underway for NASH


CymaBay Therapeutics, Inc. (NASDAQ: CBAY), today announced... read more

Tue, 10/30/18 - 10:23 am
Janssen Unveils Positive Ph III Results for Symtuza in HIV-1 Patients


 
Janssen Pharmaceutical today unveiled 96-week results from the pivotal Phase 3 AMBER study of Symtuza (darunavir 800 mg, cobicistat 150 mg, emtricitabine 200 mg and tenofovir alafenamide... read more

Tue, 10/30/18 - 09:53 am
U.S. DOD Purchases Banyan Biomarkers' Brain Injury Blood Tests
  • Banyan BTI is the first test to aid in the diagnosis of concussion
  • The U.S. CDC estimates there are more than 2.5 million emergency room visits annually in the U.S. alone
... read more
Tue, 10/30/18 - 09:44 am
Innovate Biopharmaceuticals Announces Promising Results of Larazotide in NASH Study
  • Larazotide is a tight junction regulator
  • The drug is also in Ph III trials for celiac disease
  • The FDA awarded fast track status to Larazotide for celiac
  • If approved... read more
Mon, 10/29/18 - 09:45 am

Pages